Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Appropriate Inhaler Use of Tiotropium As Add-on Therapy in Symptomatic Asthma [NA]
This completed clinical trial from Chang Gung Memorial Hospital examined tiotropium as add-on inhaler therapy in patients with symptomatic a…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: The Effectiveness and Safety of Dupilumab in Children with Asthma in China: a Real-world Study
A real-world study examining the effectiveness and safety of dupilumab for children with asthma in China; the trial is currently enrolling b…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: FeNO Detection in Asthma Diagnosis: A New Technology Approach [NA]
A clinical trial sponsored by Novlead Inc. is evaluating a FeNO-based technology to aid asthma diagnosis and is currently recruiting.
-
EMA approval · 2025-02-27EMA Authorised: Fasenra (Benralizumab) — AstraZeneca AB
EMA authorised Fasenra (benralizumab) for asthma. The marketing authorisation holder is AstraZeneca AB; decision date 13/02/2025.
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Retrospective Study of Patients with Acute Presentation for Asthma to an Emergency Department in UK (RAPAE)
A retrospective study of patients presenting with acute asthma to a UK emergency department (RAPAE), sponsored by Norfolk and Norwich Univer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Accuracy of the Association Between the "PA-R" and "ACT" Questionnaires in Asthmatic Pediatric Patients [NA]
This update reports a clinical trial evaluating how accurately the PA-R and ACT questionnaires measure asthma symptoms in pediatric patients…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Impulse Oscillometry Measurements in Severe Eosinophilic Asthmatics Before and After Anti-IL-5 Factor Initiation
Completed study in severe asthma assessing impulse oscillometry before and after initiation of an IL-5 pathway inhibitor, with results poste…
-
CLINICAL_TRIALS other · 2025-02-24Clinical Trial Update: The Importance of Tailored Education And Device Handling for Asthmatic Patients
A clinical trial update from Chiesi Hungary Ltd. outlines a study on tailored education and device handling for asthma patients. The trial s…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo Nation [NA]
Clinical trial update describing a collaboration to reduce childhood asthma disparities on the Navajo Nation; the study is currently active …
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Association Between Genetic Polymorphisms and Type 2 Asthma in Children
A recruiting study evaluating whether genetic polymorphisms are associated with Type 2 inflammatory asthma in children.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion [Phase 2]
Phase 2 study evaluating the efficacy and safety of HSK31858 tablets in patients with airway mucus hypersecretion; the trial is currently en…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Stem Cell Strategies for the Treatment of Chronic Asthma
Clinical trial update on stem cell strategies for chronic asthma; the study is currently ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma
ClinicalTrials.gov update describes a study examining the effect of mepolizumab on structural and inflammatory cells in adults with severe e…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: DOSE Trial: Optimal Dose of Oral Corticosteroids to Treat Asthma Exacerbations [Phase 4]
A Phase 4 clinical trial update for the DOSE Trial investigates the optimal oral corticosteroid dose to treat asthma exacerbations, and the …
-
EMA approval · 2025-02-18EMA Authorised: GoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) (Budesonide;formoterol fumarate dihydrate) — Teva Pharma B.V.
The European Medicines Agency authorised GoResp Digihaler, a budesonide/formoterol inhalation therapy by Teva Pharma B.V. (previously Budeso…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Prospective Study on Asthma Control
The document covers a completed prospective study on asthma control sponsored by Chiesi Farmaceutici S.p.A.
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Treatable Traits of Severe Asthma [NA]
Status update for the clinical trial NCT06811740 on treatable traits of severe asthma; the study is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Chronic Airway Disease and Multimorbidity Cohort
A prospective cohort clinical trial on chronic airway disease and multimorbidity is currently recruiting, involving COPD, asthma, and bronch…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma [NA]
Clinical trial update on pharmacodynamic equivalence between test and reference inhalers containing albuterol sulfate in adults with stable …
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Retrieval of Economic Incentives and Information on Quality-of-care Indicators in Primary Care [NA]
A clinical trial update from Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina about retrieving economic incentives and quality…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment [Phase 3]
Phase 3 multicenter randomized non-inferiority trial evaluating an investigational asthma/COPD treatment from Eurofarma has completed.
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Evaluation of 3D Magnetic Resonance Spirometry: Comparison with Spirometry in Healthy Subjects and Patients with Respiratory Pathologies (asthma, COPD, Bilateral Lung Transplant) [NA]
A clinical trial evaluating 3D magnetic resonance spirometry and its comparison with conventional spirometry in healthy subjects and patient…
-
FDA approval · 2025-02-13FDA Approved: PREDNISOLONE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental Abbreviated New Drug Application for a generic prednisolone product from PAI Holdings/PAI Pharma, signaling regu…
-
FDA approval · 2025-02-11FDA Approved: FORMOTEROL FUMARATE — Original Application (Devatis, Inc.)
FDA approved the original application (ANDA) for Formoterol Fumarate Dihydrate, the generic form of Formoterol Fumarate, manufactured by Dev…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Stress and Treatment Response in Puerto Rican Children With Asthma
The document notes the completion of a University of Pittsburgh–sponsored clinical trial studying stress and treatment response in Puerto Ri…